1. Home
  2. KRMD vs KTTA Comparison

KRMD vs KTTA Comparison

Compare KRMD & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KORU Medical Systems Inc. (DE)

KRMD

KORU Medical Systems Inc. (DE)

HOLD

Current Price

$5.58

Market Cap

288.6M

Sector

Health Care

ML Signal

HOLD

Logo Pasithea Therapeutics Corp.

KTTA

Pasithea Therapeutics Corp.

HOLD

Current Price

$1.22

Market Cap

5.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRMD
KTTA
Founded
1980
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
288.6M
5.3M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
KRMD
KTTA
Price
$5.58
$1.22
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
1
Target Price
$5.88
$3.00
AVG Volume (30 Days)
179.3K
578.4K
Earning Date
11-12-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$39,070,637.00
N/A
Revenue This Year
$23.36
N/A
Revenue Next Year
$18.63
N/A
P/E Ratio
N/A
N/A
Revenue Growth
22.12
N/A
52 Week Low
$1.86
$0.28
52 Week High
$6.61
$3.85

Technical Indicators

Market Signals
Indicator
KRMD
KTTA
Relative Strength Index (RSI) 49.22 58.07
Support Level $5.55 $1.09
Resistance Level $6.61 $1.30
Average True Range (ATR) 0.35 0.09
MACD -0.09 -0.01
Stochastic Oscillator 14.13 60.27

Price Performance

Historical Comparison
KRMD
KTTA

About KRMD KORU Medical Systems Inc. (DE)

KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).

Share on Social Networks: